Chris Gibson built the pioneering AI biotech Recursion Pharmaceuticals on a foundation of bold promises. But after more than ...
How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...
Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...
Hungarian low-cost airline giant Wizz Air backtracks on plans to gradually resume flights to and from Tel Aviv’s Ben Gurion Airport later this month, instead extending the suspension of services to ...
Researchers in Spain have identified a new source of underperformance in utility-scale PV plants caused by “suboptimal backtracking” on slightly uneven terrain. The study shows that real tracker ...
Hungarian low-cost airline giant Wizz Air backtracks on plans to gradually resume flights to and from Tel Aviv’s Ben Gurion Airport later this month, instead extending the suspension of services to ...
Automakers Are Backtracking on EV Plans: Here's the Electric Vehicles That Were Prematurely Canceled
Just a few years ago, the transition to a market full of electric vehicles seemed inevitable, and the vast majority of automakers proclaimed that their lineups would become fully electrified over the ...
A good sum of two good parts. Our research team assigns Gold ratings to strategies that they have the most conviction will outperform their Morningstar Category average over a market cycle on a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results